DISEASE/TRAIT,RISK ALLELE FREQUENCY,P-VALUE,REGION,SNPS,MAPPED_GENE,Groups of Disease/Trait,RISK ALLELE FREQUENCY (%)
Breast cancer,0.979,4e-07,14q24.3,rs9323635,LINC02289,Cancer,97.89999999999999
Appendicular lean mass,0.942827,2e-10,10p11.23,rs776620768,ZNF438,Body measurement,94.28269999999999
"Allergic disease (asthma, hay fever or eczema)",0.93,6e-11,1p34.3,rs76167968,Y_RNA - ZMYM4,Immune system disease,93.0
Chronotype,0.9011,2e-10,16q13,rs6499821,GNAO1-DT,Other trait,90.11
Platelet count,0.875528,5e-20,11q24.3,rs2268607,FLI1,Hematological measurement,87.55279999999999
Neuritic plaque,0.87,2e-06,12p13.31,rs7294478,C1RL-AS1,Other trait,87.0
Hepatitis A virus cellular receptor 2 level in Chronic kidney disease with hypertension and no diabetes (5134_52),0.87,7e-21,5q33.3,rs977257,HAVCR2,Cardiovascular disease,87.0
Atrial fibrillation,0.85084,3e-25,10q22.2,rs10824026,"SYNPO2L-AS1, SYNPO2L",Other trait,85.084
Prostate cancer,0.85,2e-18,19q13.33,rs2735839,KLK3 - KLK2,Cancer,85.0
Intraocular pressure,0.84,7e-07,3q21.2,rs893830,KALRN,Other trait,84.0
Post bronchodilator FEV1/FVC ratio,0.812,3e-06,15q25.1,rs2568497,CRABP1 - IREB2,Other trait,81.2
Post bronchodilator FEV1,0.811,2e-07,15q25.1,rs2568497,CRABP1 - IREB2,Other trait,81.10000000000001
Adult body size,0.766902,3e-104,18q21.32,rs58084604,RNU4-17P - MC4R,Other trait,76.6902
Chronic lymphocytic leukemia,0.73,9e-08,16q24.1,rs305061,LINC02132 - LINC01082,Cancer,73.0
Asthma and hay fever,0.72,1e-08,16p13.13,rs62026376,CLEC16A,Immune system disease,72.0
Multiple sclerosis,0.702,1e-06,1p36.32,rs60733400,TNFRSF14 - PRXL2B,Immune system disease,70.19999999999999
Estimated glomerular filtration rate,0.6992,2e-20,10q26.13,rs1055256,EEF1AKMT2,Other trait,69.92
Reticulocyte count,0.693733,2e-11,20p13,rs554743,ADAM33,Other trait,69.3733
Eosinophil counts,0.670339,7e-19,19p13.11,rs7245672,PBX4,Other trait,67.0339
Basophil count,0.666338,5e-38,1p22.3,rs1888341,LINC02801,Other trait,66.6338
Hand grip strength,0.658,4e-12,17q21.32,rs2288278,"HOXB3, HOXB-AS3",Other trait,65.8
Triglycerides,0.6572,1e-22,11p11.2,rs7120118,NR1H3,Lipid or lipoprotein measurement,65.72
Highest math class taken,0.6527,2e-10,1q42.12,rs55755259,STUM,Other trait,65.27
Apolipoprotein A1 levels,0.649794,9e-65,11q12.2,rs174566,"FADS1, FADS2",Lipid or lipoprotein measurement,64.9794
Lymphocyte count,0.64215,4e-31,7q32.3,rs7793008,LINC-PINT,Other trait,64.215
Smoking initiation (ever regular vs never regular) (MTAG),0.633,4e-20,2q36.3,rs4674993,NYAP2,Other trait,63.3
Blood protein levels,0.63171875,3e-26,19p13.3,rs11666373,AZU1 - PRTN3,Other trait,63.171875
Menopause (age at onset),0.63,1e-08,14q24.2,rs8010674,DCAF4 - ZFYVE1,Other trait,63.0
Plateletcrit,0.627322,4e-20,11q24.3,rs2268607,FLI1,Hematological measurement,62.732200000000006
Myeloproliferative neoplasms,0.6075,3e-07,3q21.3,rs9864772,LINC01565 - RPN1,Cancer,60.75000000000001
Educational attainment (MTAG),0.6017,1e-57,2q11.2,rs13018640,AFF3 - LINC01104,Other trait,60.17
Dementia with Lewy bodies,0.6,1e-08,16p11.2,rs897984,"MIR4519, BCL7C, MIR762HG",Nervous system disease,60.0
Glycine levels,0.5906,3e-12,2q34,rs1861072,UNC80,Other trait,59.06
Alzheimer's disease with no specific cognitive domain impairment,0.59,4e-06,2q31.1,rs4972634,LINC01960 - RPSAP24,Nervous system disease,59.0
Body size at age 10,0.586164,1e-31,3p22.2,rs2268762,ACVR2B,Other trait,58.6164
Prostate-specific antigen levels,0.58,6e-37,19q13.33,rs2735839,KLK3 - KLK2,Immune system disease,57.99999999999999
Ewing sarcoma,0.58,4e-17,10q21.3,rs224278,EGR2 - RNU6-543P,Cancer,57.99999999999999
Heparin-induced thrombocytopenia,0.56,9e-06,12q24.33,rs905227,ZNF84,Hematological measurement,56.00000000000001
Migraine - clinic-based,0.56,4e-06,6q25.2,rs2186141,RNU6-896P - HMGB3P19,Nervous system disease,56.00000000000001
Electrocardiogram morphology (amplitude at temporal datapoints),0.555249,3e-11,11q22.1,rs671333,ARHGAP42,Cardiovascular disease,55.5249
Waist-to-hip ratio adjusted for BMI,0.5547,5e-14,2q14.2,rs332105,THORLNC - LINC01956,Body measurement,55.47
IgA nephropathy,0.5479392320332094,8e-08,1p36.13,rs2240335,PADI4,Immune system disease,54.79392320332094
Mean platelet volume,0.542183,2.0000000000000002e-298,17q11.2,rs9891920,TAOK1,Hematological measurement,54.2183
Depressive symptoms (MTAG),0.5313,7e-09,14q24.3,rs4553560,PROX2,Liver enzyme measurement,53.13
Monocyte count,0.5097,9e-44,16q24.1,rs305064,LINC02132 - LINC01082,Other trait,50.970000000000006
Highest math class taken (MTAG),0.5009,6e-20,6q16.1,rs12208753,MMS22L - MIR2113,Other trait,50.09
Illicit drug use,0.492,9e-06,17q25.3,rs4788985,SEPTIN9,Response to drug,49.2
Serum metabolite levels,0.491175,3e-56,11q12.2,rs174567,"FADS2, FADS1",Other trait,49.1175
Mitochondrial DNA levels,0.4821,5e-23,20p11.23,rs11697739,SNX5,Other trait,48.209999999999994
Uterine fibroids,0.4791,8e-09,13q14.11,rs6563812,LINC00598,Other trait,47.910000000000004
Bioavailable testosterone levels,0.463062,5e-09,3p25.3,rs573833,ATP2B2,Other measurement,46.3062
Urinary metabolite levels in chronic kidney disease,0.46,4e-20,16q24.3,rs2250598,DPEP1,Other disease,46.0
Male-pattern baldness,0.452029,2e-09,12q24.21,rs35514224,TBX3-AS1 - UBA52P7,Other trait,45.2029
Serum levels of protein CHRDL2,0.448,2e-17,11q13.4,rs6592590,POLD3 - RN7SKP297,Other trait,44.800000000000004
"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",0.447,2e-13,16p13.13,rs2041733,CLEC16A,Immune system disease,44.7
"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",0.447,2e-13,16p13.13,rs2041733,CLEC16A,Immune system disease,44.7
Cytomegalovirus antibody response,0.44,5e-06,12p13.32,rs4766152,CRACR2A,Response to drug,44.0
Mean spheric corpuscular volume,0.436831,3e-11,11q24.3,rs2250322,FLI1,Other trait,43.6831
Mean corpuscular volume,0.436795,1e-09,11q24.3,rs2250322,FLI1,Other trait,43.6795
Hematocrit,0.435711,2e-36,16q24.3,rs2250598,DPEP1,Hematological measurement,43.5711
Autoimmune thyroid disease,0.43,2e-11,12q13.2,rs2271194,ERBB3,Immune system disease,43.0
Cholesteryl ester levels,0.4248,1e-07,11q12.2,rs174566,"FADS1, FADS2",Other trait,42.480000000000004
HDL cholesterol,0.42,4e-08,11p11.2,rs7120118,NR1H3,Cardiovascular disease,42.0
Polycystic ovary syndrome,0.42,5e-09,12q13.2,rs2271194,ERBB3,Other disease,42.0
Crohn's disease (indolent vs progressive),0.419929,4e-06,7p22.2,rs4723416,SDK1,Digestive system disease,41.9929
Phosphatidylethanolamine (18:0_18:2) levels,0.409153,1e-92,11q12.2,rs174567,"FADS2, FADS1",Other trait,40.9153
Phosphatidylcholine (17:0_18:2) levels,0.408433,9e-53,11q12.2,rs174566,"FADS1, FADS2",Other trait,40.8433
Phosphatidylinositol (18:0_18:2) levels,0.408433,4e-67,11q12.2,rs174566,"FADS1, FADS2",Other trait,40.8433
Phosphatidylcholine (O-18:2_16:0) levels,0.408433,4e-18,11q12.2,rs174566,"FADS1, FADS2",Other trait,40.8433
Phosphatidylcholine (15:0_18:2) levels,0.408433,1e-73,11q12.2,rs174566,"FADS1, FADS2",Other trait,40.8433
Eosinophil percentage of white cells,0.397535,9e-10,8p21.2,rs4733063,PTK2B,Other trait,39.7535
Ulcerative colitis,0.38,6e-06,2q24.1,rs8179646,LINC01958 - RPLP0P7,Digestive system disease,38.0
Sex hormone-binding globulin levels,0.379996,4e-18,19p13.11,rs11666808,IQCN,Other trait,37.9996
Sex hormone-binding globulin levels adjusted for BMI,0.379996,2e-11,6q25.1,rs1738386,ESR1,Body measurement,37.9996
BMI at birth,0.376996,5e-17,17p13.1,rs739669,"DLG4, ACADVL",Body measurement,37.6996
Longevity,0.37,1e-07,14q23.3,rs1950902,MTHFD1,Other trait,37.0
Alanine aminotransferase levels,0.37,2e-09,19p13.11,rs11666808,IQCN,Liver enzyme measurement,37.0
Metabolic biomarkers (multivariate analysis),0.37,9e-24,19p13.11,rs11666808,IQCN,Metabolic disease,37.0
Self-reported math ability,0.3699,1e-08,16q23.3,rs4075464,CDH13,Other trait,36.99
Myeloblastin levels,0.363884,1.0000000000000001e-124,19p13.3,rs3786991,AZU1 - PRTN3,Liver enzyme measurement,36.3884
Aspartate aminotransferase platelet ratio index in high alcohol intake,0.3502,2e-08,11q12.2,rs174566,"FADS1, FADS2",Hematological measurement,35.02
Serum alkaline phosphatase levels,0.35,7e-65,11q12.2,rs174566,"FADS1, FADS2",Other trait,35.0
IgG glycosylation,0.346381764494382,2e-08,6p21.32,rs1049110,HLA-DQB2,Immune system disease,34.6381764494382
Vertex-wise sulcal depth,0.34,2.9999999999999987e-47,10p11.23,rs2000099,ZNF438,Liver enzyme measurement,34.0
Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction),0.3269,4e-09,5q13.3,rs167025,LINC01331,Body measurement,32.690000000000005
Waist-to-hip ratio adjusted for body mass index,0.3269,6e-09,5q13.3,rs167025,LINC01331,Body measurement,32.690000000000005
Waist-to-hip ratio adjusted for BMI in active individuals,0.3259,3e-06,5q13.3,rs167025,LINC01331,Nervous system disease,32.59
Psoriasis vulgaris,0.3201,5e-17,6q23.3,rs610604,TNFAIP3,Immune system disease,32.01
Cutaneous psoriasis,0.3201,8e-11,6q23.3,rs610604,TNFAIP3,Immune system disease,32.01
Psoriatic arthritis,0.32,8e-09,6q23.3,rs610604,TNFAIP3,Other trait,32.0
Delta-5 desaturase activity response to n3-polyunsaturated fat supplement,0.32,1e-12,11q12.2,rs174566,"FADS1, FADS2",Response to drug,32.0
Risk-taking tendency (4-domain principal component model),0.2975,7e-10,3p14.2,rs10866054,CADPS,Other trait,29.75
QRS duration,0.295492,4.0000000000000004e-24,12q24.21,rs7966651,TBX3-AS1 - UBA52P7,Other trait,29.5492
Cigarettes smoked per day (MTAG),0.293,7e-16,1q21.3,rs2072659,CHRNB2,Immune system disease,29.299999999999997
Ectonucleoside triphosphate diphosphohydrolase 5 levels,0.287053,1.9999999999999998e-32,14q24.3,rs1968105,PTGR2,Other trait,28.7053
Serum levels of protein CLEC11A,0.2857,1e-16,19q13.33,rs62112533,CLEC11A - GPR32P1,Other trait,28.57
Triglyceride to HDL cholesterol ratio,0.2846,2e-12,7p15.2,rs7786102,LINC03007 - MIR148A,Cardiovascular disease,28.46
Kidney stones,0.268,2e-08,3q21.1,rs7627468,CASR,Other trait,26.8
Suffering from nerves,0.263176,5e-10,18q21.32,rs11665052,RNU4-17P - MC4R,Other trait,26.317600000000002
Puberty onset,0.26,5e-06,1p36.23,rs1149332,CAMTA1,Other trait,26.0
Multiple system atrophy,0.24,7e-06,19q12,rs11084877,LINC02987 - MAN1A2P1,Other trait,24.0
Obesity,0.24,2e-36,18q21.32,rs538656,RNU4-17P - MC4R,Metabolic disease,24.0
Systemic lupus erythematosus,0.237,5e-43,6p21.32,rs7753017,HLA-DQB2,Immune system disease,23.7
Feeling worry,0.236497,7e-10,18q21.32,rs58084604,RNU4-17P - MC4R,Other trait,23.649700000000003
Body mass index in physically inactive individuals,0.2354,2e-11,18q21.32,rs17782313,RNU4-17P - MC4R,Nervous system disease,23.54
Predicted visceral adipose tissue,0.2347,1.9999999999999998e-54,18q21.32,rs538656,RNU4-17P - MC4R,Other trait,23.47
Neurociticism,0.224224,6e-09,9p23,rs11496294,AKAP8P1 - JKAMPP1,Nervous system disease,22.4224
Sudden cardiac arrest,0.22,4e-08,5q22.2,rs4621553,YTHDC2 - KCNN2,Other trait,22.0
Feeling nervous,0.216145,1e-10,6p21.32,rs377763,NOTCH4 - TSBP1-AS1,Nervous system disease,21.6145
Positive affect,0.2144,2e-06,11p11.2,rs10769190,PHF21A - FBLIM1P2,Other trait,21.44
Obesity-related traits,0.213,3e-07,7p15.3,rs10950840,LINC01162 - RN7SL542P,Metabolic disease,21.3
Immature fraction of reticulocytes,0.203393,3e-15,20q11.22,rs2425044,EIF6,Other trait,20.339299999999998
High light scatter reticulocyte percentage of red cells,0.203377,2e-21,20q11.22,rs2425044,EIF6,Other trait,20.3377
Sick sinus syndrome,0.201,8e-10,16q22.3,rs12932445,ZFHX3,Other disease,20.1
First fracture in long-term childhood cancer survivors (time to event),0.2,8e-09,16p13.3,rs1406815,HAGHL,Cancer,20.0
Smoking initiation (ever regular vs never regular),0.2,5e-14,2q36.3,rs4674993,NYAP2,Other trait,20.0
Basal cell carcinoma,0.1836,3.0000000000000004e-81,20p13,rs214803,TGM3,Cancer,18.360000000000003
Keratinocyte cancer (MTAG),0.179072,6e-66,20p13,rs214803,TGM3,Cancer,17.9072
Medication use (agents acting on the renin-angiotensin system),0.177701,7e-11,17p13.2,rs12453576,LINC01975,Response to drug,17.7701
Adiponectin levels,0.162,2e-06,14q32.11,rs12887387,RN7SKP255 - CHORDC2P,Other trait,16.2
Brain surface area change rate x age interaction (2df),0.1593,2e-08,19q13.32,rs34342646,NECTIN2,Nervous system disease,15.93
Educational attainment,0.1584,2e-11,1p35.1,rs28438078,CSMD2,Other trait,15.840000000000002
Facial emotion recognition (angry faces),0.156,3e-06,12p11.22,rs4930838,CCDC91 - FAR2,Other trait,15.6
Cognitive performance,0.1398,9e-06,13q31.2,rs969962,TET1P1 - LINC00373,Nervous system disease,13.98
Cerebral amyloid deposition (PET imaging),0.13,2e-12,19q13.32,rs34342646,NECTIN2,Other trait,13.0
Diastolic blood pressure,0.1259,2e-08,17q21.32,rs890431,HOXB7,Cardiovascular disease,12.590000000000002
Mean arterial pressure,0.1258,2e-10,17q21.32,rs890431,HOXB7,Cardiovascular measurement,12.58
Neuroticism,0.1142,3e-08,3p21.31,rs57838764,RASSF1,Nervous system disease,11.42
Hypertension,0.1026,1e-06,17q21.32,rs7406910,HOXB7,Cardiovascular disease,10.26
Smoking behaviour (cigarettes smoked per day),0.102,3e-13,1q21.3,rs2072659,CHRNB2,Immune system disease,10.2
CD20 on CD24+ CD27+ B cell,0.09172,1e-11,11q12.2,rs139706128,MS4A14,Other trait,9.171999999999999
Low hand grip strength,0.08854,2e-06,11q11,rs118154365,OR4A9P - OR4X7P,Other trait,8.854
Fever in mesalamine-treated irritable bowel disease,0.0823,1e-07,22q13.1,rs397822879,TPTEP2-CSNK1E - KCNJ4,Digestive system disease,8.23
Diastolic blood pressure night-to-day ratio in hypertension,0.08,2e-06,14q32.2,rs4905794,RPL3P4 - BCL11B,Cardiovascular disease,8.0
Systolic blood pressure night-to-day ratio in hypertension,0.08,1e-08,14q32.2,rs4905794,RPL3P4 - BCL11B,Cardiovascular disease,8.0
Glomerular filtration rate change in heart transplantation,0.08,2e-06,5q31.3,rs918378,HMHB1 - RN7SL87P,Cardiovascular disease,8.0
alpha-2-macroglobulin receptor-associated protein levels,0.0620102,6e-29,4p16.3,rs11549516,LRPAP1,Liver enzyme measurement,6.20102
Diisocyanate-induced asthma,0.001,1e-06,12q13.13,rs59448276,"KRT86, KRT81",Immune system disease,0.1
